CAR T-cell therapy is expected to expand quickly across autoimmune skin diseases following an anticipated regulatory approval that might come as soon as this year.
CAR-T cell therapies are transforming the treatment of previously incurable blood cancers. Six approved CAR-T products have been administered to more than 20,000 people, and more than 500 clinical ...
CAR T cells—that is, T cells that have been taken from patients, engineered to express chimeric antigen receptors (CARs), and returned to patients to fight cancer—don’t always perform like champions.
CAR-T cell therapies are transforming the treatment of previously incurable blood cancers, but a large proportion of patients still responds only poorly or not at all to them, calling for new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results